The results confirmed that PPAR signature was involved in cancer-related pathways including focal adhesion, pathways in cancer, WNT signaling pathway, TGF-β signaling pathway, bladder cancer, and MAPK signaling pathway. This evidence concerns the gene TGFB1 and urinary bladder cancer.